Online citations, reference lists, and bibliographies.

Oxidative Stress And Bladder Cancer Carcinogenesis: Early Detection And Chemoprevention Involving Nrf2—an Integrative Approach

Constance Lay Lay Saw
Published 2018 · Medicine
Cite This
Download PDF
Analyze on Scholarcy
Share
Oxidative stress is a driver of many diseases, including cancer. Nuclear factor (erythroid-derived 2) like 2 (Nrf2 or NFE2L2) provides cellular defense against oxidative stress by regulating antioxidant response element (ARE)-mediated phase II detoxifying/antioxidant enzymes. This protective role is evident from studies on bladder cancer (BCa) pathogenesis. This article reviews the impact of excessive oxidative stress on bladder carcinogenesis, aiming to understand what is happening from an epidemiological perspective concerning its burden and management, as well as to discuss the challenges including high relapse rate. Two measures are proposed for reducing the burden and better management: first, promote early diagnosis of BCa with fluorescence cystoscopy; second, increase dietary intake of nutraceuticals that demonstrate functional antioxidative Nrf2. Such an integrative approach may provide a better prognostic outcome for BCa patients or people who are at higher risk of developing BCa.
This paper references
10.1007/s40495-015-0024-z
Cruciferous Vegetables, Isothiocyanates, and Prevention of Bladder Cancer
Omkara Lakshmi M. Veeranki (2015)
Elevated urinary total sialic acid and Curr Pharmacol Rep (2018) 4:482–490 489 increased oxidative stress in patients with bladder cancer
J Opanuraks (2010)
10.3892/ol.2017.6570
Application of pirarubicin photosensitizer fluorescence cystoscopy in early detection of bladder cancer
Bo Jiang (2017)
10.3322/caac.21387
Cancer Statistics, 2017.
Rebecca L Siegel (2017)
10.2478/abm-2010-0092
Elevated urinary total sialic acid and increased oxidative stress in patients with bladder cancer
Julin Opanuraks (2010)
10.1016/S0022-5347(05)67357-0
Fluorescence detection of flat bladder carcinoma in situ after intravesical instillation of hypericin.
Marie-Ange D'Hallewin (2000)
10.1016/j.eururo.2016.05.041
EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016.
Marko Babjuk (2017)
10.1097/01.mou.0000240312.16324.9a
Fluorescence cystoscopy: is it ready for use in routine clinical practice?
Philippe E. Spiess (2006)
10.2174/187152012803833026
Plants vs. cancer: a review on natural phytochemicals in preventing and treating cancers and their druggability.
Hu Wang (2012)
10.1158/1055-9965.EPI-10-0008
Intake of Cruciferous Vegetables Modifies Bladder Cancer Survival
Li Tang (2010)
10.1371/journal.pone.0059638
Oxidative Status and Lipofuscin Accumulation in Urothelial Cells of Bladder in Aging Mice
Martina Perše (2013)
10.11569/wcjd.v16.i33.3792
Role of the c-Jun N-terminal kinase signaling pathway in SW480 cell apoptosis in response to 5-aminolevulinic acid-based photodynamic therapy
Jiang-hua Zheng (2008)
10.1016/0378-4274(95)03553-2
Chemoprotection against cancer by phase 2 enzyme induction.
P. G. Talalay (1995)
10.1158/0008-5472.CAN-12-4499
Nrf2 prevents initiation but accelerates progression through the Kras signaling pathway during lung carcinogenesis.
Hironori Satoh (2013)
10.1021/tx2005025
Pharmacodynamics of ginsenosides: antioxidant activities, activation of Nrf2, and potential synergistic effects of combinations.
Constance Lay Lay Saw (2012)
10.1039/B602807A
Spectroscopic characterization and photobleaching kinetics of hypericin-N-methyl pyrrolidone formulations.
Constance Lay Lay Saw (2006)
10.1016/j.eururo.2013.06.003
EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2013.
Marko Babjuk (2013)
10.1038/bjc.2013.280
Cancer chemoprevention: a rapidly evolving field
William P. Steward (2013)
10.1016/j.fct.2014.07.038
The berry constituents quercetin, kaempferol, and pterostilbene synergistically attenuate reactive oxygen species: involvement of the Nrf2-ARE signaling pathway.
Constance Lay Lay Saw (2014)
10.1016/j.canlet.2005.10.020
Delivery of hypericin for photodynamic applications.
Constance Lay Lay Saw (2006)
The nuclear factor NF-κB pathway in inflammation
T. Lawrence (2009)
10.1158/0008-5472.CAN-04-1906
Nrf2 Is Essential for the Chemopreventive Efficacy of Oltipraz against Urinary Bladder Carcinogenesis
Katsuyuki Iida (2004)
10.1179/1351000212Y.0000000031
GSTM1-null and GSTA1-low activity genotypes are associated with enhanced oxidative damage in bladder cancer
Ana Savic-Radojevic (2013)
10.1007/s00432-014-1733-0
Polymorphisms of NRF2 and NRF2 target genes in urinary bladder cancer patients
Edyta Reszka (2014)
10.1186/1476-069X-11-S1-S11
Bladder cancer, a review of the environmental risk factors
Silvia Letašiová (2012)
10.1111/j.1751-1097.2008.00384.x
Fluorescence diagnosis of bladder cancer with new water soluble hypericin bound to polyvinylpyrrolidone: PVP-hypericin.
Andreas Kubin (2008)
10.1046/j.1464-410X.2002.02690.x
Hypericin-based fluorescence diagnosis of bladder carcinoma.
Marie-Ange D'Hallewin (2002)
10.1007/s00018-009-0099-y
Reactive oxygen species-dependent signaling regulates cancer
Frank Weinberg (2009)
10.1002/bdd.759
Pharmacodynamics of dietary phytochemical indoles I3C and DIM: Induction of Nrf2-mediated phase II drug metabolizing and antioxidant genes and synergism with isothiocyanates.
Constance Lay-Lay Saw (2011)
10.1111/j.1464-410X.2005.05508.x
Is photodynamic diagnosis using hypericin better than white-light cystoscopy for detecting superficial bladder carcinoma?
Hong Gee Sim (2005)
Elevated urinary total sialic acid and Curr Pharmacol Rep increased oxidative stress in patients with bladder cancer
J Opanuraks (2010)
10.1016/1011-1344(96)07285-5
Chemical instability of 5-aminolevulinic acid used in the fluorescence diagnosis of bladder tumours.
María Novo (1996)
8-hydroxydeguanosine and nitrotyrosine are prognostic factors in urinary bladder carcinoma.
Ylermi M Soini (2011)
10.1093/jjco/hye133
An overview of the cancer control programme in Singapore.
Low Cheng Hock (2002)
10.1007/978-3-642-60258-0_10
Fluorescence Detection of Bladder Cancer
M.-A. D’Hallewin (1998)
10.1016/j.jnutbio.2015.08.001
The complexity of the Nrf2 pathway: beyond the antioxidant response.
Ying Huang (2015)
10.1016/j.freeradbiomed.2011.04.008
Arsenic-induced oxidative stress and its reversibility.
Swaran J. S. Flora (2011)
10.1002/mc.20725
Impact of Nrf2 on UVB-induced skin inflammation/photoprotection and photoprotective effect of sulforaphane.
Constance Lay Lay Saw (2011)
10.7314/APJCP.2013.14.6.3773
Oxidative stress induces hypomethylation of LINE-1 and hypermethylation of the RUNX3 promoter in a bladder cancer cell line.
Wikrom Wongpaiboonwattana (2013)
10.1002/cncr.28905
Novel endoscopic diagnosis for bladder cancer.
Seth P. Lerner (2015)
10.1002/bdd.1846
Effects of natural phytochemicals in Angelica sinensis (Danggui) on Nrf2-mediated gene expression of phase II drug metabolizing enzymes and anti-inflammation.
Constance Lay Lay Saw (2013)
10.1016/j.jphotobiol.2006.10.003
Superiority of N-methyl pyrrolidone over albumin with hypericin for fluorescence diagnosis of human bladder cancer cells implanted in the chick chorioallantoic membrane model.
Constance Lay Lay Saw (2007)
10.1007/978-3-642-16483-5_849
Carcinoma in situ.
Donald L. Lamm (1992)
10.1016/j.cotox.2016.10.008
Regulation of Keap1-Nrf2 signaling: The role of epigenetics.
David Chee-mun Cheng (2016)
10.1159/000072677
Increased Formation of 8-Hydroxy-2’-Deoxyguanosine in Peripheral Blood Leukocytes in Bladder Cancer
Tülay Akçay (2003)
10.1016/0165-1110(83)90036-2
Cell transformation by chemical agents--a review and analysis of the literature. A report of the U.S. Environmental Protection Agency Gene-Tox Program.
Charles Heidelberger (1983)
Novel endoscopic diagnosis for bladder
SP Lerner (2015)
10.1097/00005392-199707000-00017
The treated natural history of high risk superficial bladder cancer: 15-year outcome.
Michael S. Cookson (1997)
10.1016/0304-419X(81)90005-6
Two independent aspects of tumor promotion.
Isaac Berenblum (1981)
10.1089/end.2014.0282
A phase IIA dose-finding study of PVP-hypericin fluorescence cystoscopy for detection of nonmuscle-invasive bladder cancer.
Michael P. Straub (2015)
10.1097/00001622-199206000-00003
Bladder cancer.
H A Ozen (1998)
10.1002/em.21749
Evaluation of gene expression changes in human primary uroepithelial cells following 24-hr exposures to inorganic arsenic and its methylated metabolites.
Janice W. Yager (2013)
10.1016/j.pharmthera.2012.09.008
Dietary phytochemicals and cancer prevention: Nrf2 signaling, epigenetics, and cell death mechanisms in blocking cancer initiation and progression.
Jong Hun Lee (2013)
10.1016/j.fct.2013.10.023
Astaxanthin and omega-3 fatty acids individually and in combination protect against oxidative stress via the Nrf2-ARE pathway.
Constance Lay Lay Saw (2013)
10.1038/nrc3278
NRF2 and cancer: the good, the bad and the importance of context
Michael B. Sporn (2012)
10.1002/bdd.1956
Induction of NRF2-mediated gene expression by dietary phytochemical flavones apigenin and luteolin.
Ximena Paredes-Gonzalez (2015)
10.1089/ars.2010.3276
Regulation of NF-E2-related factor 2 signaling for cancer chemoprevention: antioxidant coupled with antiinflammatory.
Rong Hu (2010)
10.1002/(SICI)1097-0142(19970615)79:12<2282::AID-CNCR2>3.0.CO;2-O
5-Aminolevulinic acid-based photodynamic therapy. Clinical research and future challenges.
Qian Peng (1997)
10.1097/00000658-196806000-00002
Hematoporphyrin‐Derivative Fluorescence in Malignant Neoplasms
H B Gregorie (1965)
10.1186/1749-8546-5-37
Anti-cancer and potential chemopreventive actions of ginseng by activating Nrf2 (NFE2L2) anti-oxidative stress/anti-inflammatory pathways
Constance Lay-Lay Saw (2010)
10.1038/nature07205
Cancer-related inflammation
Alberto Mantovani (2008)
Glutathione S-transferase M 1 polymorphism and bladder cancer risk : a meta-analysis involving 50 studies
Zhi-Ping Qi (2017)
10.1186/2045-3701-4-39
Nrf2 null enhances UVB-induced skin inflammation and extracellular matrix damages
Constance Lay Lay Saw (2014)
Approaches to prevention of epithelial cancer during the preneoplastic period.
Michael B. Sporn (1976)
10.1021/jf2013875
Antioxidants in foods: state of the science important to the food industry.
John W. Finley (2011)
10.1007/128_2012_340
A perspective on dietary phytochemicals and cancer chemoprevention: oxidative stress, nrf2, and epigenomics.
Zheng-Yuan Su (2013)
10.1016/j.eururo.2016.11.029
Reply to Harry Herr's Letter to the Editor re: Marko Babjuk, Andreas Böhle, Maximilian Burger, et al. EAU Guidelines on Non-muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016. Eur Urol 2017;71:447-61.
Marko Babjuk (2017)
10.1021/MP300130K
Pharmacokinetics and pharmacodynamics of phase II drug metabolizing/antioxidant enzymes gene response by anticancer agent sulforaphane in rat lymphocytes.
Hu Wang (2012)
10.4149/NEO_2013_016
Expression of NRF2 and NRF2-modulated genes in peripheral blood leukocytes of bladder cancer males.
Edyta Reszka (2013)
10.1258/ebm.2011.010295
Glutathione S-transferase M1 polymorphism and bladder cancer risk: a meta-analysis involving 33 studies
Zheng Jiang (2011)
10.1074/jbc.R900010200
The Nrf2-Antioxidant Response Element Signaling Pathway and Its Activation by Oxidative Stress*
Truyen Nguyen (2009)
10.1111/j.1600-079X.2010.00756.x
Effect of melatonin on the expression of Nrf2 and NF-kappaB during cyclophosphamide-induced urinary bladder injury in rat.
Durga Nand Tripathi (2010)
10.1016/j.urolonc.2014.02.006
The Nrf2 transcription factor contributes to resistance to cisplatin in bladder cancer.
Annette L. Hayden (2014)
antioxidant coupled with antiinflammatory
R Hu (2018)
10.1080/10408398.2010.499481
Antioxidants in Food: Mere Myth or Magic Medicine?
Ralf G Berger (2012)
10.1007/s00204-011-0675-4
Nrf2: control of sensitivity to carcinogens
Stephen L. Slocum (2011)



Semantic Scholar Logo Some data provided by SemanticScholar